Tags

Type your tag names separated by a space and hit enter

A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice.
Psychopharmacology (Berl). 2010 Aug; 211(3):277-89.P

Abstract

RATIONALE

Heavy cannabis use is linked with an increased risk for schizophrenia. We showed previously that male heterozygous neuregulin 1 transmembrane domain (Nrg1 HET) mice are more sensitive to some effects of the psychotropic cannabis constituent Delta(9)-tetrahydrocannabinol (THC). We report data from a follow-up study in female Nrg1 HET mice, investigating THC effects on behaviours with some relevance to schizophrenia.

METHODS

Mice were injected with THC (0, 5 or 10 mg/kg i.p.) 30 min before a test battery: open field, elevated plus maze, novel object recognition (set 1) or light-dark, social interaction (SI) and prepulse inhibition (PPI 1: variable interstimulus interval (ISI); set 2). Another set (set 3) was injected with the same doses of THC before a fixed interstimulus interval PPI test (PPI 2).

RESULTS

Female Nrg1 HETs displayed the hallmark increased locomotor activity at 5 months and anxiolytic-like behaviour in the open field at 3 and 5 months. THC decreased locomotor activity in both genotypes. THC selectively reduced some SI behaviours in WT mice. Baseline PPI was enhanced in mutants under a variable ISI, while THC had no effect on PPI using either protocol.

CONCLUSIONS

This study reports novel findings on the baseline PPI profile and resistance to THC-induced social withdrawal in female Nrg1 HET mice. This is the first description of THC effects in females of this mouse model and suggests that the transmembrane domain Nrg1 mutation does not appear to have a severe impact on the behavioural sensitivity to THC in female mice.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Long LE
Schizophrenia Research Institute, 405 Liverpool St., Darlinghurst, NSW 2010, Australia. l.long@powmri.edu.au
Chesworth R
No affiliation info available
Arnold JC
No affiliation info available
Karl T
No affiliation info available

MeSH

AnimalsDisease Models, AnimalDronabinolExploratory BehaviorFemaleGenotypeHeterozygoteMaze LearningMemoryMiceMice, Mutant StrainsMotor ActivityNeuregulin-1Reflex, StartleSchizophreniaSocial Behavior

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20571781

Citation

Long, Leonora E., et al. "A Follow-up Study: Acute Behavioural Effects of Delta(9)-THC in Female Heterozygous Neuregulin 1 Transmembrane Domain Mutant Mice." Psychopharmacology, vol. 211, no. 3, 2010, pp. 277-89.
Long LE, Chesworth R, Arnold JC, et al. A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. Psychopharmacology (Berl). 2010;211(3):277-89.
Long, L. E., Chesworth, R., Arnold, J. C., & Karl, T. (2010). A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. Psychopharmacology, 211(3), 277-89. https://doi.org/10.1007/s00213-010-1896-6
Long LE, et al. A Follow-up Study: Acute Behavioural Effects of Delta(9)-THC in Female Heterozygous Neuregulin 1 Transmembrane Domain Mutant Mice. Psychopharmacology (Berl). 2010;211(3):277-89. PubMed PMID: 20571781.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. AU - Long,Leonora E, AU - Chesworth,Rose, AU - Arnold,Jonathon C, AU - Karl,Tim, Y1 - 2010/06/23/ PY - 2009/12/22/received PY - 2010/05/23/accepted PY - 2010/6/24/entrez PY - 2010/6/24/pubmed PY - 2010/10/16/medline SP - 277 EP - 89 JF - Psychopharmacology JO - Psychopharmacology (Berl) VL - 211 IS - 3 N2 - RATIONALE: Heavy cannabis use is linked with an increased risk for schizophrenia. We showed previously that male heterozygous neuregulin 1 transmembrane domain (Nrg1 HET) mice are more sensitive to some effects of the psychotropic cannabis constituent Delta(9)-tetrahydrocannabinol (THC). We report data from a follow-up study in female Nrg1 HET mice, investigating THC effects on behaviours with some relevance to schizophrenia. METHODS: Mice were injected with THC (0, 5 or 10 mg/kg i.p.) 30 min before a test battery: open field, elevated plus maze, novel object recognition (set 1) or light-dark, social interaction (SI) and prepulse inhibition (PPI 1: variable interstimulus interval (ISI); set 2). Another set (set 3) was injected with the same doses of THC before a fixed interstimulus interval PPI test (PPI 2). RESULTS: Female Nrg1 HETs displayed the hallmark increased locomotor activity at 5 months and anxiolytic-like behaviour in the open field at 3 and 5 months. THC decreased locomotor activity in both genotypes. THC selectively reduced some SI behaviours in WT mice. Baseline PPI was enhanced in mutants under a variable ISI, while THC had no effect on PPI using either protocol. CONCLUSIONS: This study reports novel findings on the baseline PPI profile and resistance to THC-induced social withdrawal in female Nrg1 HET mice. This is the first description of THC effects in females of this mouse model and suggests that the transmembrane domain Nrg1 mutation does not appear to have a severe impact on the behavioural sensitivity to THC in female mice. SN - 1432-2072 UR - https://www.unboundmedicine.com/medline/citation/20571781/A_follow_up_study:_acute_behavioural_effects_of_Delta_9__THC_in_female_heterozygous_neuregulin_1_transmembrane_domain_mutant_mice_ L2 - https://dx.doi.org/10.1007/s00213-010-1896-6 DB - PRIME DP - Unbound Medicine ER -